XXII - 22nd Century GroupAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $0.64 | Open | $0.64 |
| Volume | 11.4K | Market Cap | 90.26M |
| Yield | Last Dividend |
| 22nd Century Group Provides Strategy Upd... | 09/24/20 |
| WILLIAMSVILLE, N.Y., Sept. 24, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (???22nd Century??? or ???the Company???), a le... | |
| Cannabis Movers & Shakers: Target Capita... | 09/18/20 |
| Here???s the summary of the latest corporate shake-ups in the cannabis industry. Target Capital Names 2 Directors Target Capital Inc. ??? doing ??? | |
| 22nd Century Group (XXII) Presents At LD... | 09/04/20 |
| The following slide deck was published by 22nd Century Group, Inc. in conjunction with this event.. | |
| ???High??? hopes for 22nd Century Group | 07/29/20 |
| 22nd Century Group Inc is a plant biotechnology company, which provides technology that allows increasing or decreasing the level of nicotine in tobac... | |
| 22nd Century Group to Host Webcast of 20... | 07/09/20 |
| WILLIAMSVILLE, N.Y., July 09, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (???22nd Century??? or ???the Company???), a lea... | |
| A Director at 22nd Century (XXII) is Buy... | 06/30/20 |
| Yesterday, a Director at 22nd Century (XXII), Nora Sullivan, bought shares of XXII for $17.16K. Following this transaction Nora Sullivan's holding in ... | |
| 22nd Century Group names new leaders | 06/03/20 |
| 22nd Century Group has new leaders. James A. Mish was appointed CEO of the Clarence-based tobacco products company, effective June 22, and John Franzi... | |
| 22nd Century Group Appoints James A. Mis... | 06/03/20 |
| Mish brings extensive global executive leadership experience in the development, manufacturing and commercialization of active pharmaceutical ingredie... | |
| Cannabis Stock Gainers And Losers From M... | 03/17/20 |
| Gainers Australis Capital (OTC: AUSAF ) shares closed up 37.48% at $0.14 Marrone Bio Innovations (NASDAQ: MBII ) shares closed up 22.79% at $0.88 Corb... | |
| 22nd Century Group Files 2019 Annual Rep... | 03/12/20 |
| Cannabis genetics research comapny 22nd Century Group filed its annual report for the year ended December 31, 2019. The post 22nd Century Group Files ... | |
| FDA Scientific Advisory Committee Discus... | 02/18/20 |
| WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE American: XXII) ??? a plant biotechnology company that is a leader in reduced nic... | |
| 22nd Century Group???s FDA Advisory Comm... | 02/11/20 |
| WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE American: XXII)???a plant biotechnology company that is a leader in tobacco harm ... | |
| FDA authorizes low-nicotine cigarettes b... | 12/17/19 |
| The FDA cleared applications from 22nd Century Group for its Moonlight and Moonlight Menthol cigarettes, which contain less nicotine than conventional... | |
| 22nd Century Enters CBD Space With $24M ... | 12/05/19 |
| 22nd Century Group Inc (NYSE: XXII ) a plant biotechnology company focused on tobacco and cannabis plant research, on Wednesday announced the initial ... | |
| Shareholder Alert: Robbins LLP Reminds I... | 12/03/19 |
| SAN DIEGO & WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)---- $XXII #ClassAction--Shareholder rights law firm Robbins LLP reminds investors that purchasers of ... | |
| 22nd Century Group Files 2019 Third Quar... | 11/07/19 |
| WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm r... | |
| Will 22nd Century Group Continue to Surg... | 08/26/19 |
| As of late, it has definitely been a great time to be an investor 22nd Century Group. | |
| Growing Body of Research Adds Credibilit... | 05/07/19 |
| NEW YORK , May 7, 2019 /PRNewswire/ -- As the burgeoning cannabis market expands around the globe, most countries have or are moving towards adopting ... | |
| OXY, SBGI, XXII and LPI among notable af... | 05/03/19 |
| No summary available. | |
| Grossly Misleading ???Short and Distort?... | 04/18/19 |
| 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, Very Low Nicotine Cont... | |
| 22nd Century - Key Patents Behind MRTP A... | 04/17/19 |
| XXII's Key QPT patents behind the tobacco used in their MRTP & PMTA applications expired in 2018. QPT expired patents are the essential patents behind... | |
| Some New Patients Choose CBD in Lieu of ... | 04/09/19 |
| NEW YORK , April 9, 2019 /PRNewswire/ -- Nearly 20% of U.S. adults suffer from chronic pain, while 8% are diagnosed with high-impact chronic pain, acc... | |
| Pawar Law Group Announces a Securities C... | 03/20/19 |
| NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purcha... | |
| 22nd Century Group, Inc. (XXII), Arlo Te... | 03/20/19 |
| NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit ha... | |
| 7-DAY DEADLINE ALERT: The Schall Law Fir... | 03/15/19 |
| LOS ANGELES, March 15, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class ac... | |
| 22nd Century Group's (XXII) CEO Henry Si... | 03/07/19 |
| No summary available. | |
| 22nd Century reports Q4 results | 03/07/19 |
| No summary available. | |
| 22nd Century Group and Tenax Therapeutic... | 03/06/19 |
| No summary available. | |
| 22nd Century Group plunges 25% on Gottli... | 03/05/19 |
| No summary available. | |
| XXII, NUVA, QURE and MGNX among notable ... | 02/08/19 |
| No summary available. | |
| Date | 2020-08-06 (AMC) | Est. (EPS/Rev.) | ($0.04)/ 5M |
| Actual (EPS/Rev.) | $-0.04/ $6.40 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Option Superstars | James Catzen | 75.00 % | Subscribe |
| 2 Weeks Scalp | profit_with_me | 54.00 % | Subscribe |
| Mojo Day Trading | ProTrader Mike | 46.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
